The South-Eastern Norway Regional Health Authority, Helse Sør-Øst RHF, have signed a deal to roll out JAC's Chemotherapy Management System (CMS) across its 17 health Trusts, satellite clinics and seven chemotherapy production pharmacies in order to help improve the quality of cancer care and patient safety across the whole region.
The contract award directly to JAC underpins Helse Sør-Øst RHF's 'Digital Modernisation Initiative - for Improved Patient Safety and Quality of Care'.
It also spearheads a new regional shared-services programme for the
standardisation and consolidation of technologies with the aim of
improving accessibility to healthcare for the 2.8 million population
living in the region.
Norway's
mountainous landscape and snowy winters make travelling and accessing
health services difficult all year round. After world-wide research,
JAC's CMS solution was identified by Helse Sør-Øst RHF as offering a
unique set of capabilities, including meeting their key requirement of a
truly regional solution capable of supporting the delivery of cancer
care to patients irrespective of where they reside.
By
taking a regional approach, Helse Sør-Øst RHF aims to improve the
cancer patients' experience by eliminating the need to travel regularly
to a main treatment facility for their weekly chemotherapy treatments
and for follow up assessments. Their medication can be prepared in any
of one of the region's seven pharmacy production units for local
delivery. In addition, the regional solution enables multi-disciplinary
teams of professionals to remotely monitor the progress of patients'
treatment and make adjustments to their medication.
No comments:
Post a Comment